ICG Silver & Gold reports Q2 results
Three large-cap companies — Globus Medical (GMED), Pan American Silver (PAAS), and Kinross Gold (KGC) — are currently trading at discounted prices despite attracting minimal analyst coverage. In a market where most megacaps garner over 30 analysts per stock, these three have analyst coverage ranging from 8 to 13. Analysts anticipate a 34.6% upside for GMED, while PAAS and KGC have delivered impressive earnings growth rates, with the former posting a staggering 133% EPS growth and the latter 112%.
Despite these strong fundamentals, all three stocks have declined over the past six months, leaving a significant gap between their earnings potential and market valuation. GMED presents the most compelling investment opportunity due to its high fair-value upside and strong analyst revision momentum. The gold miners also offer commodity exposure with financially sound balance sheets at bargain valuations.
Once analysts begin paying attention to these companies, their valuation gap may provide a substantial buying opportunity.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
